 Disease Progression
"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 | | 1996 | 0 | 5 | 5 | | 1997 | 0 | 3 | 3 | | 1998 | 0 | 12 | 12 | | 1999 | 0 | 13 | 13 | | 2000 | 0 | 14 | 14 | | 2001 | 0 | 13 | 13 | | 2002 | 0 | 16 | 16 | | 2003 | 0 | 31 | 31 | | 2004 | 0 | 26 | 26 | | 2005 | 0 | 38 | 38 | | 2006 | 1 | 37 | 38 | | 2007 | 2 | 48 | 50 | | 2008 | 2 | 64 | 66 | | 2009 | 4 | 63 | 67 | | 2010 | 4 | 71 | 75 | | 2011 | 7 | 59 | 66 | | 2012 | 3 | 76 | 79 | | 2013 | 5 | 83 | 88 | | 2014 | 5 | 72 | 77 | | 2015 | 8 | 97 | 105 | | 2016 | 7 | 84 | 91 | | 2017 | 9 | 108 | 117 | | 2018 | 9 | 98 | 107 | | 2019 | 10 | 123 | 133 | | 2020 | 3 | 103 | 106 | | 2021 | 9 | 75 | 84 | | 2022 | 0 | 46 | 46 | | 2023 | 2 | 45 | 47 | | 2024 | 26 | 48 | 74 | | 2025 | 3 | 15 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Fortis S, Strand M, Bhatt SP, Ten Eyck P, Wendt L, Parekh T, Han MK, Hokanson JE, Kinney G, Curtis JL, Bowler RP, Wan ES, Kunisaki KM, Wendt CH, Regan E, Dransfield M, Crapo JD, Silverman EK, Comellas AP. Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry. Am J Respir Crit Care Med. 2025 Jun; 211(6):957-965.
-
Jalal DI, Thurman JM, Smith RJ. Chronic kidney disease enhances alternative pathway activity: a new paradigm. J Clin Invest. 2025 May 01; 135(9).
-
Madan R, El Alam RH, Walker CM, Bang TJ, Bartel TB, Batra K, Brixey AG, Christensen JD, Cox CW, Gonzalez AV, Little BP, Lui NS, Maxfield H, Moore WH, Qin A, Shroff GS, Yasufuku K, Chung JH. ACR Appropriateness Criteria? Lung Cancer-Surveillance After Therapy. J Am Coll Radiol. 2025 May; 22(5S):S319-S342.
-
Chalmers JD, Burgel PR, Daley CL, De Soyza A, Haworth CS, Mauger D, Loebinger MR, McShane PJ, Ringshausen FC, Blasi F, Shteinberg M, Mange K, Teper A, Fernandez C, Zambrano M, Fan C, Zhang X, Metersky ML. Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. N Engl J Med. 2025 Apr 24; 392(16):1569-1581.
-
Gnanaraj R, Lisker-Cervantes A, Patnaik J, Rajeswaren V, Mehta N, Gange W, Lynch AM, Palestine A, Mathias M, Manoharan N, Mandava N, Forest TEC. Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry. BMJ Open Ophthalmol. 2025 Apr 05; 10(1).
-
Dunlay SM, Pinney SP, Lala A, Stewart GC, McIlvennan C, Wong RP, Morris AA, Pagani FD, Allen LA, Breathett K, Cogswell R, Colvin MM, Cowger JA, Drakos SG, Gelfman LP, Kanwar MK, Kiernan MS, Kittleson MM, Lewis EF, Moazami N, Ogunniyi MO, Pandey A, Rogers JG, Schumacher KR, Slaughter MS, Tedford RJ, Teuteberg J, Valantine HA, DeFilippis EM, Dixon DD, Golbus JR, Gulati G, Hanff TC, Hsiao S, Lewsey SC, McCormick AD, Nayak A, Fenton KN, Longacre LS, Shanbhag SM, Taddei-Peters WC, Stevenson LW. Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action. JAMA Cardiol. 2025 Apr 01; 10(4):391-398.
-
Lindstr?m S, Nordgaard J, Berge J. Transition from schizotypal disorder to non-affective psychotic disorders including schizophrenia: A nationwide Swedish cohort study. Psychiatry Res. 2025 Jun; 348:116470.
-
Rudy MJ, Wilson CJ, Hinckley B, Baker DC, Royal JM, Hoke MP, Brennan MB, Vogt MR, Clarke P, Tyler KL. EV68-228-N monoclonal antibody treatment halts progression of paralysis in a mouse model of EV-D68 induced acute flaccid myelitis. mBio. 2025 Apr 09; 16(4):e0390624.
-
Hong KN, Eshraghian E, Khedro T, Argir? A, Attias J, Storm G, Tsotras M, Bloks T, Jackson I, Ahmad E, Graw S, Mestroni L, Bui QM, Schwartz J, Turner S, Adler ED, Taylor M. An International Longitudinal Natural History Study of Patients With Danon Disease: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes. J Am Heart Assoc. 2025 Apr; 14(7):e038394.
-
Lewis CJ, Johnston JM, Zaragoza Domingo S, Vezina G, D'Souza P, Gahl WA, Adams DA, Tifft CJ, Acosta MT. Retrospective assessment of clinical global impression of severity and change in GM1 gangliosidosis: a tool to score natural history data in rare disease cohorts. Orphanet J Rare Dis. 2025 Mar 14; 20(1):125.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|